Non-Invasive · Light-Based · Hair Loss
Low-Level Laser Therapy for Hair
How this page was made
This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full
disclaimer for how SHEA creates and reviews treatment information.
01
What it is
Low-Level Laser Therapy (LLLT), also called photobiomodulation, uses red and near-infrared light at low energy levels, generally understood to affect cellular activity in hair follicles rather than heating or damaging tissue the way ablative or thermal lasers do. It's offered both as in-clinic panel or helmet devices and as at-home devices, sometimes sold by clinics for use between visits.
Several LLLT devices, both professional and home-use, have received FDA clearance in the US for androgenetic alopecia — device clearance, not the same regulatory pathway as drug approval. This is more regulatory recognition than many other non-surgical hair treatments have, though clearance establishes permitted device use rather than proving a specific outcome for every user.
02
Why people consider it
- Mild to moderate androgenetic alopecia, as a non-invasive, no-downtime option
- They cannot tolerate finasteride or minoxidil and want to avoid or reduce medication use
- They're considering it as a complement to existing medical therapy
03
What the experience is like
In-clinic sessions typically use a panel, hood, or helmet device covering the scalp for 20 to 30 minutes; most people feel little to nothing during treatment, and there's no recovery period or activity restriction afterward. Protocols commonly involve multiple sessions per week over a period of months, followed by maintenance use — ask your clinic what schedule they recommend and why.
Results, when they occur, develop gradually; most people don't notice a change until several months of consistent use. Stopping treatment is generally understood to result in a gradual return toward the baseline rate of hair loss — this is a maintenance approach, not a one-time treatment.
04
Limitations & considerations
- Long-standing complete baldness is unlikely to respond, as with other non-surgical hair treatments
- Whether adding LLLT to minoxidil provides a meaningful additional benefit is genuinely disputed in the current literature — see the Evidence Note below
- Studies use different devices, wavelengths, and protocols, which limits how well findings from one device generalize to another; if buying or using an at-home device, confirm its specific regulatory clearance rather than assuming all LLLT devices are equivalent
- Sustained, consistent use over months is required to produce and maintain results
- No specific outcome can be guaranteed
Evidence note
A 2026 open-label prospective study (68 participants, 12 months) using a home-use helmet-type LLLT device found an average increase of 25 hairs/cm² and a 15% increase in hair thickness, with no reported adverse events. This was not placebo-controlled, so the result can't rule out other contributing factors.
The question of whether adding LLLT to topical minoxidil improves outcomes over minoxidil alone is genuinely unsettled: two systematic reviews published within weeks of each other in early 2025 reached opposite conclusions. One (7 RCTs) found the combination associated with significantly greater hair density and diameter increases than minoxidil alone. A separate review (4 RCTs, 188 participants) found no statistically significant difference between the two, with its authors explicitly concluding that adding LLLT may not be worth the added cost and complexity for this specific comparison. A separate individual randomized trial (54 participants) also found no significant difference in hair density between the combination and minoxidil alone, though it did report LLLT was safe and well tolerated.
A broader systematic review of LLLT across male and female pattern hair loss (298 articles screened, 36 focused on LLLT) found generally supportive evidence for LLLT increasing hair density and diameter, while noting the field includes substantial variation in devices and protocols.
References
Peer-reviewed literature and regulatory sources.
1. Shin JW, Paik K, Na JI, Lew BL, Huh CH. Long-Term Efficacy and Safety of Low-Level Laser Therapy for Androgenetic Alopecia: A 12-Month Prospective Trial. Dermatologic Therapy, 2026;2026:6621458.
Peer-reviewed · Open-label prospective study (n=68) · No placebo control
2. Comparative efficacy and safety of low-level laser therapy and topical Minoxidil combination vs. topical Minoxidil monotherapy in androgenetic alopecia management: a systematic review and meta-analysis of randomized controlled trials. Lasers in Medical Science, 2025;40:213.
Peer-reviewed · Systematic review and meta-analysis (7 RCTs) · Found combination superior
3. Alosaimi A, Algarni A, Alharbi A, et al. Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis. Journal of Dermatological Treatment, 2025;36(1):2447355.
Peer-reviewed · Systematic review and meta-analysis (4 RCTs, n=188) · Found no significant difference
4. Gentile P, Garcovich S. The Effectiveness of Low-Level Light/Laser Therapy on Hair Loss. Facial Plastic Surgery & Aesthetic Medicine, 2024.
Peer-reviewed · Systematic review (36 LLLT-focused studies)
5. Systematic Review and Meta-analysis of Randomized Controlled Trials of FDA-Cleared, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
Peer-reviewed · Systematic review and meta-analysis